SCHEMBL825623

SCHEMBL825623

CC(F)(F)[CH]Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6228142 0.76
SCHEMBL9349690 0.76
SCHEMBL939689 0.75
SCHEMBL1078180 0.75
SCHEMBL7251608 0.75
SCHEMBL7455641 0.73
SCHEMBL7798940 0.70
SCHEMBL1316614 0.70
SCHEMBL7452630 0.68
SCHEMBL1021061 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067604-A1 COMBINATIONS OF IRS/STAT3 DUAL MODULATORS AND ANTI PD-1/PD-L1 ANTIBODIES FOR TREATING CANCER TYRNOVO LTD. (IL) 2024-02-29 US disclosed
WO-2024003906-A1 CANNABINOID DERIVATIVES AND COMPOSITIONS COMPRISING SAME CANNASOUL ANALYTICS LTD. (IL) 2024-01-04 WO disclosed
US-20230399324-A1 AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS RYCARMA THERAPEUTICS, INC. 2023-12-14 US disclosed
EP-4247778-A1 AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS Armgo Pharma, Inc. (US) 2023-09-27 EP disclosed
WO-2023084516-A1 NOVEL CANNABINOID DERIVATIVES CANNASOUL ANALYTICS LTD. (IL) 2023-05-19 WO disclosed
US-20220185797-A1 SELECTIVE FOXO INHIBITORS FOR TREATMENT OF DIABETES AND OTHER DISORDERS RELATED TO IMPAIRED PANCREATIC FUNCTION THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2022-06-16 US disclosed
WO-2022108945-A1 AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS ARMGO PHARMA, INC. (US) 2022-05-27 WO disclosed
US-11243186-B2 Chemically sensitive field effect transistors and uses thereof in electronic nose devices TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2022-02-08 US disclosed
US-20210364461-A1 CHEMICALLY SENSITIVE SENSOR COMPRISING MICRO-BARRIER AND METHOD OF FABRICATION THEREOF TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2021-11-25 US disclosed
US-20210220297-A1 COMBINATIONS OF IRS/STAT3 DUAL MODULATORS AND ANTI-CANCER AGENTS FOR TREATING CANCER TYRNOVO LTD. (IL) 2021-07-22 US disclosed
WO-2010079490-A1 VOLATILE ORGANIC COMPOUNDS AS DIAGNOSTIC MARKERS IN THE BREATH FOR LUNG CANCER TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2010-07-15 WO disclosed
US-20100056635-A1 NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2010-03-04 US disclosed
WO-2009147682-A1 NOVEL MODULATORS OF PROTEIN KINASE SIGNALING NOVOTYR THERAPEUTICS LTD. (IL) 2009-12-10 WO disclosed
WO-2009144725-A1 CARBON NANOTUBE STRUCTURES IN SENSOR APPARATUSES FOR ANALYZING BIOMARKERS IN BREATH SAMPLES TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2009-12-03 WO disclosed
EP-2125712-A1 NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF Novotyr Therapeutics Ltd. (IL) 2009-12-02 EP disclosed
WO-2009118739-A1 CHEMICAL SENSORS BASED ON CUBIC NANOPARTICLES CAPPED WITH AN ORGANIC COATING FOR DETECTING EXPLOSIVES TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2009-10-01 WO disclosed
WO-2009104180-A1 NITROGEN OXIDE SENSITIVE FIELD EFFECT TRANSISTORS FOR EXPLOSIVE DETECTION COMPRISING FUNCTIONALIZED NON-OXIDIZED SILICON NANOWIRES TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2009-08-27 WO disclosed
WO-2009066293-A1 CHEMICAL SENSORS BASED ON CUBIC NANOPARTICLES CAPPED WITH AN ORGANIC COATING TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2009-05-28 WO disclosed
WO-2009013754-A1 CHEMICALLY SENSITIVE FIELD EFFECT TRANSISTORS AND USE THEREOF IN ELECTRONIC NOSE DEVICES TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2009-01-29 WO disclosed
WO-2008068751-A1 NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF NOVOTYR THERAPEUTICS LTD. (IL) 2008-06-12 WO disclosed